US Stock MarketDetailed Quotes

GMVDF G Medical Innovations

Watchlist

0.009
0.0000.00%

15min DelayClose Jul 22 09:30 ET

301.29KMarket Cap0.00P/E (TTM)

G Medical Innovations Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

(Q1)Mar 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-60.77%-18.48M

-147.34%-11.49M

26.20%-4.65M

-6.3M

Net income from continuing operations

-68.36%-25.07M

-17.34%-14.89M

18.19%-12.69M

----

---15.51M

----

Operating gains losses

-3,219.66%-9.79M

44.76%-295K

-67.40%-534K

----

---319K

----

Depreciation and amortization

-11.01%1.21M

-3.95%1.36M

-50.59%1.42M

----

--2.87M

----

Other non cash items

-132.88%-1.24M

843.64%3.78M

322.11%401K

----

--95K

----

Change In working capital

187.41%1.84M

-302.40%-2.11M

-59.25%1.04M

----

--2.55M

----

-Change in receivables

2,410.00%753K

103.50%30K

-306.25%-858K

----

--416K

----

-Change in inventory

-662.64%-2.02M

-192.01%-265K

-70.52%288K

----

--977K

----

-Change in payables and accrued expense

266.65%3.11M

-214.56%-1.87M

6.54%1.63M

----

--1.53M

----

-Change in other working capital

----

72.22%-5K

95.12%-18K

----

---369K

----

Cash from discontinued investing activities

Operating cash flow

-60.77%-18.48M

-147.34%-11.49M

26.20%-4.65M

----

---6.3M

----

Investing cash flow

Cash flow from continuing investing activities

-12,388.24%-2.12M

96.26%-17K

-6.06%-455K

19.75%-126K

100.57%1K

91.17%-429K

98.62%-27K

72.55%-70K

-157K

-176K

Net PPE purchase and sale

-331.40%-2.09M

4.54%-484K

-18.18%-507K

----

81.13%-429K

----

Net other investing changes

-107.49%-35K

798.08%467K

--52K

19.75%-126K

100.57%1K

----

27.03%-27K

72.55%-70K

---157K

---176K

Cash from discontinued investing activities

Investing cash flow

-12,388.24%-2.12M

96.26%-17K

-6.06%-455K

19.75%-126K

100.57%1K

91.17%-429K

98.62%-27K

72.55%-70K

---157K

---176K

Financing cash flow

Cash flow from continuing financing activities

-13.92%14.86M

220.95%17.27M

31.09%5.38M

47.50%2.57M

-4.17%942K

-53.63%4.1M

-90.87%449K

-72.93%793K

1.74M

983K

Net issuance payments of debt

147.84%9.54M

206.59%3.85M

-188.01%-3.61M

-224.53%-2.17M

-90.13%97K

-47.94%4.1M

-89.80%449K

-72.93%793K

--1.74M

--983K

Net common stock issuance

-75.25%3.32M

49.21%13.42M

--8.99M

--4.94M

--845K

----

Proceeds from stock option exercised by employees

--2M

--0

----

Net other financing activities

----

---206K

----

Cash from discontinued financing activities

Financing cash flow

-13.92%14.86M

220.95%17.27M

31.09%5.38M

47.50%2.57M

-4.17%942K

-53.63%4.1M

-90.87%449K

-72.93%793K

--1.74M

--983K

Net cash flow

Beginning cash position

2,070.50%6.03M

--278K

--0

-81.37%185K

-103.53%-93K

-81.40%2.63M

-92.45%181K

-89.01%352K

--993K

--2.63M

Current changes in cash

-199.70%-5.74M

1,970.50%5.76M

110.60%278K

154.41%358K

117.35%278K

77.12%-2.62M

-205.95%-267K

74.28%-187K

---658K

---1.6M

Effect of exchange rate changes

--0

----

80.65%-12K

53.33%-7K

120.00%16K

--17K

---39K

End cash Position

-95.11%295K

2,070.50%6.03M

--278K

54.26%543K

-81.37%185K

--0

-103.53%-93K

-92.45%181K

--352K

--993K

Free cash flow

-71.04%-20.6M

-133.68%-12.04M

23.37%-5.15M

7.05%-2.08M

72.40%-665K

62.26%-6.73M

74.56%-689K

73.24%-910K

---2.24M

---2.41M

Currency Unit

USD

Accounting Standards

US-GAAP

	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019	(Q1)Mar 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-60.77%-18.48M	-147.34%-11.49M	26.20%-4.65M			-6.3M
Net income from continuing operations	-68.36%-25.07M	-17.34%-14.89M	18.19%-12.69M	----	----	---15.51M	----	----	----	----
Operating gains losses	-3,219.66%-9.79M	44.76%-295K	-67.40%-534K	----	----	---319K	----	----	----	----
Depreciation and amortization	-11.01%1.21M	-3.95%1.36M	-50.59%1.42M	----	----	--2.87M	----	----	----	----
Other non cash items	-132.88%-1.24M	843.64%3.78M	322.11%401K	----	----	--95K	----	----	----	----
Change In working capital	187.41%1.84M	-302.40%-2.11M	-59.25%1.04M	----	----	--2.55M	----	----	----	----
-Change in receivables	2,410.00%753K	103.50%30K	-306.25%-858K	----	----	--416K	----	----	----	----
-Change in inventory	-662.64%-2.02M	-192.01%-265K	-70.52%288K	----	----	--977K	----	----	----	----
-Change in payables and accrued expense	266.65%3.11M	-214.56%-1.87M	6.54%1.63M	----	----	--1.53M	----	----	----	----
-Change in other working capital	----	72.22%-5K	95.12%-18K	----	----	---369K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-60.77%-18.48M	-147.34%-11.49M	26.20%-4.65M	----	----	---6.3M	----	----	----	----
Investing cash flow
Cash flow from continuing investing activities	-12,388.24%-2.12M	96.26%-17K	-6.06%-455K	19.75%-126K	100.57%1K	91.17%-429K	98.62%-27K	72.55%-70K	-157K	-176K
Net PPE purchase and sale	-331.40%-2.09M	4.54%-484K	-18.18%-507K	----	----	81.13%-429K	----	----	----	----
Net other investing changes	-107.49%-35K	798.08%467K	--52K	19.75%-126K	100.57%1K	----	27.03%-27K	72.55%-70K	---157K	---176K
Cash from discontinued investing activities
Investing cash flow	-12,388.24%-2.12M	96.26%-17K	-6.06%-455K	19.75%-126K	100.57%1K	91.17%-429K	98.62%-27K	72.55%-70K	---157K	---176K
Financing cash flow
Cash flow from continuing financing activities	-13.92%14.86M	220.95%17.27M	31.09%5.38M	47.50%2.57M	-4.17%942K	-53.63%4.1M	-90.87%449K	-72.93%793K	1.74M	983K
Net issuance payments of debt	147.84%9.54M	206.59%3.85M	-188.01%-3.61M	-224.53%-2.17M	-90.13%97K	-47.94%4.1M	-89.80%449K	-72.93%793K	--1.74M	--983K
Net common stock issuance	-75.25%3.32M	49.21%13.42M	--8.99M	--4.94M	--845K	----	----	----	----	----
Proceeds from stock option exercised by employees	--2M	--0	--0	----	----	----	----	----	----	----
Net other financing activities	----	----	----	---206K	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-13.92%14.86M	220.95%17.27M	31.09%5.38M	47.50%2.57M	-4.17%942K	-53.63%4.1M	-90.87%449K	-72.93%793K	--1.74M	--983K
Net cash flow
Beginning cash position	2,070.50%6.03M	--278K	--0	-81.37%185K	-103.53%-93K	-81.40%2.63M	-92.45%181K	-89.01%352K	--993K	--2.63M
Current changes in cash	-199.70%-5.74M	1,970.50%5.76M	110.60%278K	154.41%358K	117.35%278K	77.12%-2.62M	-205.95%-267K	74.28%-187K	---658K	---1.6M
Effect of exchange rate changes	--0	--0	--0	----	----	80.65%-12K	53.33%-7K	120.00%16K	--17K	---39K
End cash Position	-95.11%295K	2,070.50%6.03M	--278K	54.26%543K	-81.37%185K	--0	-103.53%-93K	-92.45%181K	--352K	--993K
Free cash flow	-71.04%-20.6M	-133.68%-12.04M	23.37%-5.15M	7.05%-2.08M	72.40%-665K	62.26%-6.73M	74.56%-689K	73.24%-910K	---2.24M	---2.41M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall